We enrolled 82 non-cachectic patients, mean age 61 ± 13 years, with ejection fraction <40 % and predischarge New York Heart Association (NYHA) functional classes II–IV. All patients underwent clinical examination, two-dimensional echocardiography and NT-proBNP, GH and IGF-I measurement with log IGF-I/GH ratio calculation. Mortality and clinical status was documented at follow-up (18.4 ± 8.1 months).
During follow-up 17 patients died of cardiac causes. Non-survivors were at baseline in higher NYHA class (P < 0.05) and showed higher values of NT-proBNP (P < 0.001) than survivors; differently IGF-I, and log IGF-I/GH ratio were lower (P < 0.05). At Cox multivariate analysis, NT-proBNP (P < 0.001) and IGF-I/GH ratio (P < 0.05) were independent predictors of death.
High NT-proBNP levels and low IGH-I/GH ratio may be useful to stratify CHF patients at higher risk of cardiac death.